Get the Stockscreener App
0.2249
7.03%
-0.017
Fibrobiologics Inc stock is traded at $0.2249, with a volume of 21.50M.
It is down -7.03% in the last 24 hours and down -17.92% over the past month.
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
See More
Previous Close:
$0.2419
Open:
$0.2693
24h Volume:
21.50M
Relative Volume:
12.18
Market Cap:
$14.96M
Revenue:
-
Net Income/Loss:
$-17.78M
P/E Ratio:
-0.4095
EPS:
-0.5492
Net Cash Flow:
$-10.52M
1W Performance:
-4.66%
1M Performance:
-17.92%
6M Performance:
-63.85%
1Y Performance:
-88.76%
1-Day Range:
$0.2212
$0.2694
1-Week Range:
$0.2212
$0.2694
52-Week Range:
$0.2201
$2.335
Fibrobiologics Inc Stock (FBLG) Company Profile
Name
Fibrobiologics Inc
Sector
Industry
Phone
281-671-5150
Address
455 E. MEDICAL CENTER BLVD, HOUSTON
Compare FBLG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.2249 | 16.09M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.36 | 115.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.87 | 81.34B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.65 | 52.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
840.95 | 51.59B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.04 | 37.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Initiated | Rodman & Renshaw | Buy |
| Oct-30-24 | Initiated | H.C. Wainwright | Buy |
| Sep-24-24 | Initiated | Maxim Group | Buy |
Fibrobiologics Inc Stock (FBLG) Latest News
FibroBiologics files IND application for psoriasis treatment - Investing.com India
FibroBiologics Announces IND Filing for CYPS317 Therapy for Moderate to Severe Psoriasis - Quiver Quantitative
Fibrobiologics stock rises after FDA filing for psoriasis treatment - Investing.com
Experimental cell therapy for hard-to-treat psoriasis moves to FDA review - Stock Titan
Why FibroBiologics Inc. stock remains resilientPortfolio Value Report & Entry Point Strategy Guides - Улправда
Activity Recap: Why FibroBiologics Inc. (SG0) stock attracts wealthy investorsJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Улправда
Will FibroBiologics Inc. stock gain from strong economy2025 Pullback Review & Free Safe Capital Growth Stock Tips - Улправда
Is FibroBiologics Inc. stock supported by strong cash flows2025 Macro Impact & AI Powered Market Entry Strategies - Улправда
How strong is FibroBiologics Inc. stock revenue growthOptions Play & Momentum Based Trading Ideas - Улправда
Can FibroBiologics Inc. (SG0) stock hold up in economic slowdownMarket Sentiment Summary & Risk Controlled Daily Trade Plans - Bölüm Sonu Canavarı
Market Fear: Why FibroBiologics Inc. stock is in analyst buy zoneJuly 2025 Technicals & Consistent Growth Equity Picks - Улправда
Will FibroBiologics Inc. stock reach all time highs in 2025Trade Performance Summary & Fast Gain Stock Tips - ulpravda.ru
Why FibroBiologics Inc. (SG0) stock attracts wealthy investorsInsider Buying & Real-Time Stock Entry Alerts - Улправда
What drives FibroBiologics Inc stock pricePrice Action Analysis & Low Cost Wealth Plans - earlytimes.in
How interest rate cuts could boost FibroBiologics Inc. stockStock Surge & Stock Market Timing Techniques - Улправда
FibroBiologics (NASDAQ: FBLG) seeks reverse split and warrant share votes - Stock Titan
FibroBiologics prices 5.23M shares at 33c in registered direct offering - MSN
FibroBiologics closes $1.7 million registered direct offering By Investing.com - Investing.com Australia
Quarterly Earnings: Why analysts remain bullish on FibroBiologics Inc stockStop Loss & Daily Entry Point Alerts - moha.gov.vn
FibroBiologics closes $1.7 million registered direct offering - Investing.com
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering and Private Placement of Unregistered Warrants - Quiver Quantitative
FibroBiologics Announces Closing of $1.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewswire
FibroBiologics enters securities purchase agreement - MSN
Biotech targeting chronic diseases raises $1.7M in stock sale - Stock Titan
FibroBiologics announces $1.7M registered direct offering - MSN
FibroBiologics Enters Securities Purchase Agreement - TipRanks
FibroBiologics (NASDAQ: FBLG) sells 5.2M shares at $0.33 with paired warrants - Stock Titan
Hedge Fund and Insider Trading News: AQR Capital Management, Bridgewater Associates, Shiprock Capital Management, Totus Capital, Sage Capital, Global Payments Inc (GPN), FibroBiologics Inc. (FBLG), and More - Insider Monkey
FibroBiologics raises $1.7 million in registered direct offering By Investing.com - Investing.com Nigeria
FibroBiologics raises $1.7 million in registered direct offering - Investing.com India
Fibrobiologics prices $1.7 million direct offering on Nasdaq - marketscreener.com
Fibrobiologics Prices $1.7 Million Direct Offering on Nasdaq - TradingView — Track All Markets
FibroBiologics (Nasdaq: FBLG) prices $1.7M direct sale and related $1.7M warrants - Stock Titan
FibroBiologics submits new patent application with USPTO - MSN
FibroBiologics Stock Surges 54%, With A 7-Day Winning Spree - Trefis
Major Stock Acquisition: Insider Buys Big in FibroBiologics! - TipRanks
Garcia, FibroBiologics general counsel, buys $47,600 in stock By Investing.com - Investing.com Australia
Garcia, FibroBiologics general counsel, buys $47,600 in stock - Investing.com
Officer Garcia Buys 140,000 ($47.6K) Of FibroBiologics Inc [FBLG] - TradingView — Track All Markets
FibroBiologics Director Ruben A. Garcia Acquires 140,000 Shares - TradingView — Track All Markets
FibroBiologics (NASDAQ:FBLG) Trading 4.8% Higher – What’s Next? - Defense World
FibroBiologics files patent for fibroblast therapy in joint repair By Investing.com - Investing.com Nigeria
Why Is FibroBiologics Stock Trading Higher Today?FibroBiologics (NASDAQ:FBLG) - Benzinga
FibroBiologics files patent for fibroblast therapy in joint repair - Investing.com
FibroBiologics Submits New Patent Application for Fibroblast-Derived Therapy in Orthopedic and Musculoskeletal Conditions - Quiver Quantitative
FibroBiologics Files Patent Application Covering Novel - GlobeNewswire
FibroBiologics Files Patent Application Covering Novel Fibroblast-Based Chondrocyte Spheroid Platform for Orthopedic and Musculoskeletal Conditions - The Manila Times
FibroBiologics Inc (FBLG) shows promising results - uspostnews.com
Does FibroBiologics Inc (FBLG) offer a good opportunity for investors? - Setenews
FibroBiologics announces payoff of outstanding debt - MSN
Will FibroBiologics Inc. (SG0) stock deliver stable dividendsRisk Management & Expert Approved Momentum Trade Ideas - Newser
Fibrobiologics Inc Stock (FBLG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fibrobiologics Inc Stock (FBLG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Khoja Hamid | Chief Scientific Officer |
May 27 '25 |
Buy |
0.84 |
20,000 |
16,800 |
31,250 |
0.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):